Acasă › Cancer de prostată › District of Columbia › Washington
Studii clinice pentru Cancer de prostată în Washington, DC
38 studii pentru Cancer de prostată caută participanți în și în jurul orașului Washington (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
The Vanguard Study: Testing a New Way to Screen for Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- Walter Reed National Military Medical Center, Bethesda · La 7 mi distanță
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
În curs de recrutareFaza 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Collection of Blood From Patients With Prostate Cancer
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · La 7 mi distanță
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
În curs de recrutareFaza 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Precision-Based Genomics in Prostate Cancer
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Collection of Blood From Patients With Cancer
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
În curs de recrutareFaza 3
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
În curs de recrutareFaza 2
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
În curs de recrutareFaza 3
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
În curs de recrutareFaza 3
- George Washington University Medical Center, Washington D.C.
- UM Capital Region Medical Center, Largo · La 11 mi distanță
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Men at High Genetic Risk for Prostate Cancer
În curs de recrutareStudiu observațional
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
În curs de recrutareFaza 1/2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
În curs de recrutare
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
În curs de recrutareFaza 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
În curs de recrutareFaza 3
- Sibley Memorial Hospital, Washington D.C.
- Suburban Hospital, Bethesda · La 7 mi distanță
FOG-001 in Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
În curs de recrutareFaza 2
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
În curs de recrutareFaza 3
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
În curs de recrutareFaza 1
- Maryland Oncology Hematology, Silver Spring · La 7 mi distanță
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- National Institutes of Health Clinical Center, Bethesda · La 7 mi distanță
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
În curs de recrutareFaza 4
- VA Medical Center, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Cancer Support Community Research & Training Institute, Washington D.C.
Clinical Trial of Approaches to Prostate Cancer Surgery
În curs de recrutare
- Georgetown University, Washington D.C.
Castrate Resistant Prostate Cancer Enhertu Therapy
În curs de recrutareFaza 2
- Washington DC VAMC, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
În curs de recrutareFaza 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- Howard University Hospital, Washington D.C.
- National Cancer Institute, Bethesda · La 7 mi distanță
- Walter Reed National Military Medical Center, Bethesda · La 7 mi distanță
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Silver Spring · La 7 mi distanță
- Massive Bio SYNERGY-AI site, Bethesda · La 7 mi distanță
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
În curs de recrutareFaza 3
- George Washington University Medical Center, Washington D.C.
Studii pentru Cancer de prostată în alte orașe
- New York City, NY103 studii
- Houston, TX76 studii
- Los Angeles, CA61 studii
- Boston, MA59 studii
- St. Louis, MO46 studii
- Chicago, IL45 studii
- San Francisco, CA45 studii
- Philadelphia, PA44 studii
- Baltimore, MD43 studii
- Nashville, TN43 studii
- Seattle, WA42 studii
- Dallas, TX36 studii
Alte studii în Washington
- Cancer (toate tipurile)58 studii
- Cancer pulmonar cu celule non-pătrate55 studii
- Cancer de sân46 studii
- Cancer metastatic43 studii
- Cancer pulmonar41 studii
- Obezitate33 studii
- Cancer colorectal29 studii
- Boli cardiovasculare28 studii
- Cancer de vezică urinară26 studii
- Leucemie mieloasă acută24 studii
- Cancer ovarian23 studii
- Limfom23 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.